论文部分内容阅读
目的:观察、分析在子宫腺肌症患者的治疗中,总结并阐述曼月乐治疗路径的临床疗效和安全性。方法:特选取我院接收的子宫腺肌症患者84例作为研究对象;分为两组。每组42例,对照组应用米非司酮口服治疗;实验组放置曼月乐环。观察分析两组的治疗效果。结果:实验组的治疗有效率为97.6%,对照组为81.0%,实验组显著优于对照组(P<0.05);在治疗后3、6、12个月的痛经评分对比上,实验组患者明显优于对照组,两组间差异有统计学意义(P<0.05)。结论:在子宫腺肌症患者的治疗中,曼月乐治疗路径的治疗效果显著,最大程度上缓解患者的子宫腺肌症症状,值得推广。
OBJECTIVE: To observe and analyze the clinical efficacy and safety of Mirena treatment pathway in the treatment of patients with adenomyosis. Methods: 84 cases of adenomyosis received in our hospital were chosen as the research object; divided into two groups. Each group 42 cases, the control group mifepristone oral treatment; experimental group placed Mirena ring. Observation and analysis of the two groups of treatment. Results: The effective rate of treatment was 97.6% in the experimental group and 81.0% in the control group, which was significantly better in the experimental group than in the control group (P <0.05). On the comparison of dysmenorrhea scores at 3, 6 and 12 months after treatment, Obviously superior to the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: In the treatment of patients with adenomyosis, the treatment effect of Mirena is significant, which can alleviate the symptoms of adenomyosis to the greatest extent and is worth promoting.